Source: FDA, National Drug Code (US) Revision Year: 2026
ORZEYFUL contains oveporexton, an orexin receptor 2 (OX2R) agonist.
Oveporexton is described chemically as: N-{(2S,3R)-4,4-Difluoro-1-(2-hydroxy-2-methylpropanoyl)-2- [(2,3',5'-trifluoro[1,1'-biphenyl]-3-yl)methyl]pyrrolidin-3-yl}ethanesulfonamide.The molecular formula is: C23H25F5N2O4S and the molecular weight is 520.51. Oveporexton's structural formula is:
Oveporexton is a white to nearly white powder.
ORZEYFUL (oveporexton) tablets for oral administration contains 0.5 mg, 1 mg, or 2 mg of oveporexton. The inactive ingredients are hydroxypropyl cellulose, magnesium stearate, mannitol, microcrystalline cellulose, and sodium starch glycolate (type A). The tablet coating consists of calcium carbonate, ferric oxide red, ferric oxide yellow, hypromellose 2910, and polyethylene glycol 8000.
| Dosage Forms and Strengths |
|---|
|
Tablets:
|
| How Supplied | ||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Table 4 displays the strengths and identifying characteristics of ORZEYFUL (oveporexton) tablets. Table 4. Strengths and Identifying Characteristics of ORZEYFUL (oveporexton) Tablets:
Store ORZEYFUL at 20°C to 25°C (68°F to 77°F); excursions permitted from 15°C to 30°C (59°F to 86°F) [See USP Controlled Room Temperature]. Distributed by: Takeda Pharmaceuticals America, Inc., Cambridge, MA 02142 |
| Drug | Countries | |
|---|---|---|
| ORZEYFUL | United States |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.